Scientists have now validated the long-held and controversial hypothesis that antibodies — usually the “good guys” in the body’s fight against viruses — instead contribute to severe dengue virus-induced disease. The finding has major implications for the development of a first-ever vaccine against dengue virus, a growing public health threat which annually infects 50 to 100 million people worldwide, causing a half million cases of the severest form.